BOSTON--(BUSINESS WIRE)--908 Devices Inc., (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, announced that National Resilience, Inc.

The demand for producing therapeutic recombinant proteins is generating a renewed interest in perfusion cell culture technologies, leading to the development of cell culture media that can support ...

Sartorius Stedim Biotech (SSB), a leading international supplier for the biopharmaceutical industry today announced the launch of the ambr ® 250 high throughput (ht) perfusion, a new automated ...

Sartorius Stedim Biotech (SSB) said today it will integrate Repligen’s XCell™ ATF cell retention control technology into SSB’s BIOSTAT® STR large-scale single-use bioreactors to create novel perfusion ...

MEDFORD, Mass.--(BUSINESS WIRE)--Sunflower Therapeutics (Sunflower), a public benefit corporation transforming global access to protein manufacturing capacity for diverse applications, announced today ...

The term “sustainability” usually brings to mind consumer products—not life-saving biologics such as recombinant proteins, monoclonal antibodies, and vaccines. Somehow, with biologics, we overlook the ...

WALTHAM, Mass., Aug. 17, 2023 (GLOBE NEWSWIRE) -- Sartorius and Repligen Corporation (NASDAQ:RGEN) today announced the launch of an integrated bioreactor system that incorporates Repligen XCell® ATF ...

SAN ANTONIO -- Oct. 8, 2019 -- Southwest Research Institute has received new funding from the Medical Technology Enterprise Consortium (MTEC) and the Food and Drug Administration (FDA) to use an ...

Dublin, Oct. 09, 2025 (GLOBE NEWSWIRE) -- The "Perfusion Bioreactors Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product ...

(MENAFN- EIN Presswire) EINPresswire/ -- "Get 20% Off All Global Market Reports With Code ONLINE20 – Stay Ahead Of Trade Shifts, Macroeconomic Trends, And Industry Disruptors Perfusion Bioreactor With ...